134 related articles for article (PubMed ID: 8481515)
21. Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin.
Higgins DL; Lewis SD; Shafer JA
J Biol Chem; 1983 Aug; 258(15):9276-82. PubMed ID: 6409903
[TBL] [Abstract][Full Text] [Related]
22. Fibrinogen Birmingham: a heterozygous dysfibrinogenemia (A alpha 16 Arg----His) containing heterodimeric molecules.
Siebenlist KR; Prchal JT; Mosesson MW
Blood; 1988 Mar; 71(3):613-8. PubMed ID: 3345340
[TBL] [Abstract][Full Text] [Related]
23. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of fibrin polymerization by fragment d is affected by calcium, Gly-Pro-Arg and Gly-His-Arg.
Furlan M; Rupp C; Beck EA
Biochim Biophys Acta; 1983 Jan; 742(1):25-32. PubMed ID: 6824684
[TBL] [Abstract][Full Text] [Related]
25. Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation.
Lisman T; Moschatsis S; Adelmeijer J; Nieuwenhuis HK; De Groot PG
Blood; 2003 Mar; 101(5):1864-70. PubMed ID: 12411291
[TBL] [Abstract][Full Text] [Related]
26. Fibrinopeptides A and B release in the process of surface fibrin formation.
Riedel T; Suttnar J; Brynda E; Houska M; Medved L; Dyr JE
Blood; 2011 Feb; 117(5):1700-6. PubMed ID: 21106983
[TBL] [Abstract][Full Text] [Related]
27. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
Furlan M; Seelich T; Beck EA
Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
[TBL] [Abstract][Full Text] [Related]
28. Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly.
Pechik I; Yakovlev S; Mosesson MW; Gilliland GL; Medved L
Biochemistry; 2006 Mar; 45(11):3588-97. PubMed ID: 16533041
[TBL] [Abstract][Full Text] [Related]
29. Role of D and E domains in the migration of vascular smooth muscle cells into fibrin gels.
Kodama M; Naito M; Nomura H; Iguchi A; Thompson WD; Stirk CM; Smith EB
Life Sci; 2002 Jul; 71(10):1139-48. PubMed ID: 12095535
[TBL] [Abstract][Full Text] [Related]
30. Activation of platelets by alpha-thrombin is a receptor-mediated event. D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone-thrombin, but not N alpha-tosyl-L-lysine chloromethyl ketone-thrombin, binds to the high affinity thrombin receptor.
Harmon JT; Jamieson GA
J Biol Chem; 1986 Dec; 261(34):15928-33. PubMed ID: 3023333
[TBL] [Abstract][Full Text] [Related]
31. Integrin alpha IIb beta 3-mediated pp125FAK phosphorylation and platelet spreading on fibrinogen are regulated by PI 3-kinase.
Ji P; Haimovich B
Biochim Biophys Acta; 1999 Jan; 1448(3):543-52. PubMed ID: 9990307
[TBL] [Abstract][Full Text] [Related]
32. Platelet-derived microparticles associate with fibrin during thrombosis.
Siljander P; Carpen O; Lassila R
Blood; 1996 Jun; 87(11):4651-63. PubMed ID: 8639834
[TBL] [Abstract][Full Text] [Related]
33. Quantifying thrombin-catalyzed release of fibrinopeptides from fibrinogen using high-performance liquid chromatography.
Ng AS; Lewis SD; Shafer JA
Methods Enzymol; 1993; 222():341-58. PubMed ID: 8412803
[No Abstract] [Full Text] [Related]
34. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
Okumura N; Haneishi A; Terasawa F
Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
[TBL] [Abstract][Full Text] [Related]
35. Platelet interaction with polymerizing fibrin.
Niewiarowski S; Regoeczi E; Stewart GJ; Senyl AF; Mustard JF
J Clin Invest; 1972 Mar; 51(3):685-99. PubMed ID: 4622107
[TBL] [Abstract][Full Text] [Related]
36. Factor XIIIa binding to activated platelets is mediated through activation of glycoprotein IIb-IIIa.
Cox AD; Devine DV
Blood; 1994 Feb; 83(4):1006-16. PubMed ID: 7906563
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of platelet integrin alpha(IIb)beta(3) by peptides that interfere with protein kinases and the beta(3) tail.
Hers I; Donath J; Litjens PE; van Willigen G; Akkerman JW
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1651-60. PubMed ID: 10845885
[TBL] [Abstract][Full Text] [Related]
38. Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface.
Braaten JV; Jerome WG; Hantgan RR
Blood; 1994 Feb; 83(4):982-93. PubMed ID: 8111066
[TBL] [Abstract][Full Text] [Related]
39. Conservation of human fibrinogen conformation after cleavage of the B beta chain NH2 terminus.
Pandya BV; Cierniewski CS; Budzynski AZ
J Biol Chem; 1985 Mar; 260(5):2994-3000. PubMed ID: 2579073
[TBL] [Abstract][Full Text] [Related]
40. Generation and degradation of fibrinopeptide A in stored platelet concentrate.
Bode AP; Miller DT
Vox Sang; 1986; 51(3):192-6. PubMed ID: 3811318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
